Boulder Ventures — 2015 Investments
4 investments dated 2015 · listed companies and verified rows first · show all
Discovers and develops microRNA-targeting therapies for areas of high unmet medical need.
BiotechBoulder, US
William S. Marshall(Executive Officer, Director)Jason A. Leverone(Executive Officer)David Rodman(Executive Officer)Jason Leverone(Executive Officer)Christopher J Morl(Executive Officer)Christopher Bowden(Director)
Board seatKyle Lefkoff· per SEC Form D · $40.7M raise · filed Feb 2017
Co-investorsBrace PharmaMC Healthcare Ventures
Boulder, US
Richard Whitcomb(Executive Officer, Director)
BoardDmitry Akhanov(Director)John Creecy(Director)Michael Routh(Director)William Marshall(Director)
Board seatKyle Lefkoff· per SEC Form D · $2.3M raise · filed Feb 2015
Datavail provides managed database administration, applications support, business intelligence, and process automation services for enterprise organizations.
AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareSaaSBroomfield, US
Andrew Evans(Executive Officer)Mark Perlstein(Executive Officer, Director)David Boyle(Executive Officer)
BoardJack Tankersley(Director)Susan Bihler(Director)in
Board seatPeter Roshko· per SEC Form D
Co-investorsCatalyst InvestorsLead Edge Capital
BiotechWestminster, US
Michael R. Bristow(Executive Officer, Director)Thomas A. Keuer(Executive Officer)Brian L. Selby(Executive Officer)Patrick M. Wheeler(Executive Officer)Christopher D. Ozeroff(Executive Officer)
BoardDan J. Mitchell(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.